Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
Alex Brill Interviewed by Biosimilars Review & Report

Alex Brill Interviewed by Biosimilars Review & Report

Aug 6, 2025 | Interviews

Following the release of the new MGA white paper “The Long-Term Effects of Medicare Price Negotiations on Drug Competition,” Alex Brill spoke with Stanton Mehr at Biosimilars Review & Report.

IRS says it will deny most claims of pandemic tax credit for employers

IRS says it will deny most claims of pandemic tax credit for employers

Jun 30, 2024 | Interviews

“A big responsibility is falling on the IRS to deal with this problem, when, in fact, Congress could be dealing with this problem,” Brill said.”

MGA’s Alex Brill on CNBC’s Squawk Box Discussing Tackling the Tax Gap

MGA’s Alex Brill on CNBC’s Squawk Box Discussing Tackling the Tax Gap

Feb 22, 2024 | Interviews

Alex Brill joined CNBC’s “Squawk Box” to discuss the IRS’ attempt to crack down on the tax gap.

Alex Brill on Single-Payer Health Care System and Drug Costs

Alex Brill on Single-Payer Health Care System and Drug Costs

Jan 12, 2024 | Interviews

Alex Brill is a senior fellow at the American Enterprise Institute (AEI), where he studies the impact of tax policy on the US economy as well as the fiscal, economic, and political consequences of tax, budget, health care, retirement security, and trade policies.

Alex Brill mentioned on MSN

Alex Brill mentioned on MSN

Jan 6, 2024 | Interviews

If the Supreme Court rules in their favor, it could open the door to reshaping the country’s tax code.

‘The Price of Business’: A Major Fiscal Crisis is Brewing and Largely Ignored by the Media

‘The Price of Business’: A Major Fiscal Crisis is Brewing and Largely Ignored by the Media

Aug 11, 2023 | Interviews

Alex Brill joined Kevin Price on ‘The Price of Business’ to discuss the fact that the US will add over $1 trillion to the deficit in a single year.

« Older Entries
  • Analysis (53)
  • Books (3)
  • Commentary (15)
  • Events (21)
  • Interviews (60)
  • News (55)
  • Op-Eds (97)
  • Press Releases (4)
  • Testimony (21)
  • How Pharmaceutical Tariffs Will Affect US Health Care Costs
    How Pharmaceutical Tariffs Will Affect US Health Care CostsSeptember 26, 2025
  • Quantifying the economic impact of healthcare distributors
    MGA Releases New Report Quantifying the Economic Impact of Healthcare DistributorsSeptember 17, 2025
  • Unsung Hero of the OBBBA
    The Unsung Hero of the OBBBA: Permanent ExpensingAugust 20, 2025
  • Alex Brill Interviewed by Biosimilars Review & Report
    Alex Brill Interviewed by Biosimilars Review & ReportAugust 6, 2025
  • Medicare Price Negotiations and Drug Competition
    MGA Releases New White Paper on Medicare Price Negotiations and Drug CompetitionJuly 14, 2025
  • effects of 304B
    The 340B Program’s Negative Impact on Pharmaceutical InnovationJune 5, 2025
  • a conversation on tax reform
    A Conversation with House Ways and Means Committee Chairman Jason Smith on Tax ReformMarch 5, 2025
  • US Biosimilars Market
    New MGA Paper Identifies Barriers to US Biosimilar Success in the Second DecadeMarch 5, 2025
  • Congress on the Brink of Disrupting the PBM Market
    Congress on the Brink of Disrupting the PBM MarketJanuary 27, 2025
  • Raising the Salt Cap Would Increase Tax Complexity
    Raising the Salt Cap Would Increase Tax ComplexityJanuary 13, 2025
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact